TASC commercial portfolio

Tayside has continued commitment to delivery and performance in an environment where the study mix is becoming more challenging and labour-intensive.

On this page

Studies in Tayside

Tayside has taken part in 166 commercial research studies in the past 5 years (2018-2022)

 Our Tayside studies were in the following categories:

  • 75% drug trials
  • 8% questionnaire studies
  • 5% limited to data
  • 4% medical device trials
  • 8% Other studies
Pie chart showing the study percantages.

Active therapy areas

Our most active therapy areas are:

  • Cancer 23%
  • Cardiovascular 14%
  • Respiratory 13%
  • Neuroprogressive and Dementia 11%
  • Diabetes 9%
  • Dermatology 7%
  • Children, 6%
  • Other 17%
Pie chart showing active therapy area percentages.

Study recruitment

During this 5 year period we recruited 1104 participants to commercial trials in Tayside.

30 of our studies recruited to target, a further 31 over recruited and 37 studies recruited between 50% and100% of target. (2018-2022)

Bar chart showing percentage of recruitment.